Trimetazidine Hydrochloride Controlled Release Capsules 80 Mg – Zimetra 80 CR Capsules

Zimetra 80 CR Capsules – Trimetazidine Hcl 80 mg (Extended Release)

Description
Trimetazidine Hydrochloride Controlled Release Capsules 80 Mg is a controlled-release formulation of Trimetazidine Hydrochloride, an anti-anginal (anti-ischemic) agent indicated for the management of stable angina pectoris. It enhances cardiac cellular metabolism, enabling heart cells to function efficiently even under reduced oxygen supply. The controlled-release mechanism ensures gradual and steady drug delivery, maintaining stable plasma levels and providing prolonged symptom relief.

Key Benefits:
Optimizes Cardiac Metabolism: Supports efficient energy utilization in heart cells without affecting heart rate or blood pressure.
Reduces Angina Frequency: Maintains energy balance in ischemic myocardial tissue, lowering the occurrence and severity of angina episodes.
Sustained 24-Hour Control: Once-daily modified-release dosing ensures continuous symptom management and convenience for patients.

Targeted Specialties:
Cardiology
General Medicine
Geriatrics
Critical Care Medicine

 Disclaimer:
To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion.